Lung Cancer Surgery Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-589 | Report Format : | Status : Upcoming |

Abstract

Global Lung Cancer Surgery Market: Overview

Lung cancer is also known as lung carcinoma. It is malignant in nature and undergoes uncontrolled cell growth in the lung tissues. It grows beyond the lung and affects other parts of the body. It is caused due to uncontrolled growth of the abnormal cancerous cells in lungs. These cancerous cells undergo rapid division and affect the normal functioning of lung, which means it stops providing oxygen to the bloodstream. Primary lung cancer is also known as carcinomas. It occurs in the lungs whereas secondary lung cancer begins in other parts of the body.

Global Lung Cancer Surgery Market: Growth Factors

Major driving factor of the global lung cancer surgery market is genetic inheritance and inhalation of carcinogenic substances. Some of the other growth factors include arsenic, tobacco, asbestos, and radiations such as UV rays and X-rays cause carcinogens. Owing to inhalation of carcinogens substances, smoking, and genetic inheritance, chances of lung cancer increases, which in turn positively impacts the global market growth.

Global Lung Cancer Surgery Market: Segmentation

The global lung cancer surgery market is classified on the basis of microscopic observation as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Of these, non-small cell lung cancer is the leading microscopic observation segment in the global lung cancer surgery market. Non-small cell lung cancer is further sub-segmented as squamous cell carcinoma, large cell undifferentiated carcinoma, adenocarcinoma, and bronchioalveolar. Based on lung surgery, the global market is bifurcated as segmentectomy, sleeve resection, pneumonectomy, and lobectomy. In pneumonectomy, the entire lung is removed, while tiny wedge shaped lung piece is removed in segmentectomy. However, cancer affected lobe is removed in the lobectomy. In sleeve resection, removal of cancerous part of the bronchus is done and is reconnected to the healthy part of the body.

Global Lung Cancer Surgery Market: Regional Analysis

Geographically, the lung cancer surgery market is fragmented as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is the leading region in the global market for lung cancer surgery, where expensive robotic surgeries are carried out, which is anticipated to contribute to the growth of the global lung cancer surgery market in the future.

Global Lung Cancer Surgery Market: Competitive Players

Some of the key players dominating the global lung cancer surgery market are Neomend Inc., Siemens Healthcare, Ethicon Endo-Surgery Inc., Olympus Cor, and Richard Wolf GmbH.

Global Lung Cancer Surgery Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Hysteroscopic Endometrial Resection Procedures Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2285 | Report Format:

Hysteroscopic Endometrial Resection Procedures Market: Overview Hysteroscopic endometrial resection procedure is a treatment for the women that have problems with heavy menstrual bleeding and also for the women who wish to no longer have children. This treatment is very effective. The hysterosco...Read More

Home Infusion Therapy Market by Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors) by Application (Anti-Infectives, Endocrinology, Enteral nutrition, Hydration Therapy, Parenteral Nutrition): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Sep-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2278 | Report Format:

The report covers forecast and analysis for the home infusion therapy market on a global and regional level. The study provides historic data of 2014 and 2015 along with a forecast from 2016 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the home infusion therap...Read More

Laser Printable Wristbands Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2272 | Report Format:

Laser Printable Wristbands Market: Growth Factors The developments that are made in the healthcare technology is the major factor that is driving the laser printable wristbands market. The companies are making increased use of the laser printable wristbands for several purposes owing to the fact...Read More

Microsclerotherapy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2208 | Report Format:

Microsclerotherapy Treatment Market: Overview For the treatment of the spider veins, microsclerotherapy is one of the best treatment options. In this treatment, the sclerosant is injected into the body which helps in destroying the veins in a period of time and gradually disappears. The most com...Read More

Remicade Biosimilar Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2197 | Report Format:

Remicade Biosimilar Market: Overview Biosimilar is a term that is used to define a biological product type that is very much similar to the drug that is already approved by the FDA; this product is known as the reference biological product. The Remicade is an antibody that is monoclonal and is u...Read More

Choose License Type:
Latest Published Reports

View All Published Reports